Scientific Reference

LL-37 (Human Cathelicidin)

Evidence profile: Preclinical, with limited uncontrolled human reports

LL-37 is the only known human cathelicidin antimicrobial peptide, consisting of 37 amino acids and derived from the precursor protein hCAP18. It plays a critical role in innate immunity, exhibiting broad-spectrum antimicrobial activity against bacteria, viruses, and fungi while also modulating inflammatory responses and promoting tissue repair. It is most commonly studied in topical applications for wound healing, where it provides both antimicrobial protection and regenerative support. Clinical and experimental data show significant improvements in chronic wound healing, though systemic use remains less well characterized.